Tenaya Therapeutics, Inc. Unrecognized Tax Benefits
Tenaya Therapeutics, Inc. (TNYA) had Unrecognized Tax Benefits of $7.26 million as of 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-11
- 2025-12-31: Unrecognized Tax Benefits $7.26M.
- 2024-12-31: Unrecognized Tax Benefits $6.36M.
- 2023-12-31: Unrecognized Tax Benefits $4.52M.
- 2022-12-31: Unrecognized Tax Benefits $3.14M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $7.26M 10-K · filed 2026-03-11 |
| 2024-12-31 | $6.36M 10-K · filed 2026-03-11 |
| 2023-12-31 | $4.52M 10-K · filed 2026-03-11 |
| 2022-12-31 | $3.14M 10-K · filed 2025-03-10 |
| 2021-12-31 | $1.47M 10-K · filed 2024-03-18 |
| 2020-12-31 | $571.00K 10-K · filed 2023-03-08 |
| 2019-12-31 | $744.00K 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |